Samuel “Bo” Bartholomew is CEO of EvidenceCare and Managing Partner of Rockmont Investments. Bo leads EvidenceCare’s effort to empower better care decisions within the EHR so that every clinical decision will provide the right care at the right time. He also serves on the board of ProviderTrust and Mindera Health with the goal of bringing healthcare’s next generation of technology to the forefront.

Prior to EvidenceCare, Bo was CEO and founder of PharmMD (now AdhereHealth), a technology leader in medication therapy management services. He served as chief revenue officer at Shearwater Health and has been a board member of numerous health tech ventures over the years. Bo also incubated a health advocacy company and a telemedicine physician access start-up company. He spent four years with HCA’s Executive Development program, where he helped build one of HCA’s newest hospitals and then managed HCA’s oldest hospital.

Bo chairs the Board of the Nashville Fellows Program focused on training the next generation of leaders and is passionate about equipping future leaders to impact our world for good. Bo earned his MBA from Vanderbilt’s Owen School of Management and has a Masters in Christian Studies from Regent College in Vancouver, BC and his undergraduate from Davidson College in North Carolina.